Alambic Investment Management, L.P. - ANTARES PHARMA INC ownership

ANTARES PHARMA INC's ticker is ATRS and the CUSIP is 036642106. A total of 132 filers reported holding ANTARES PHARMA INC in Q1 2019. The put-call ratio across all filers is 1.05 and the average weighting 0.1%.

Quarter-by-quarter ownership
Alambic Investment Management, L.P. ownership history of ANTARES PHARMA INC
ValueSharesWeighting
Q3 2020$45,000
-64.0%
16,769
-63.2%
0.49%
+57.8%
Q2 2020$125,000
+14.7%
45,569
-1.1%
0.31%
+18.6%
Q1 2020$109,000
-80.4%
46,069
-61.0%
0.26%
-43.2%
Q4 2019$555,000
+509.9%
118,100
+254.7%
0.46%
+1123.7%
Q4 2018$91,00033,3000.04%
Other shareholders
ANTARES PHARMA INC shareholders Q1 2019
NameSharesValueWeighting ↓
Sargent Investment Group, LLC 3,096,355$8,422,0005.18%
JW Asset Management, LLC 1,920,524$5,224,0003.85%
Healthcare Value Capital, LLC 250,000$680,0002.64%
ARMISTICE CAPITAL, LLC 10,300,000$28,016,0002.12%
Broadfin Capital, LLC 3,444,147$9,368,0001.23%
PERKINS CAPITAL MANAGEMENT INC 409,000$1,112,0000.86%
MYCIO WEALTH PARTNERS, LLC 1,896,500$5,158,0000.48%
ESSEX INVESTMENT MANAGEMENT CO LLC 1,012,600$2,754,0000.22%
FALCON POINT CAPITAL, LLC 130,200$354,0000.21%
Brown Advisory Securities, LLC 275,000$781,0000.15%
View complete list of ANTARES PHARMA INC shareholders